Vyalev is the first subcutaneous 24-hour continuous infusion of levodopa-based therapy for advanced Parkinson’s disease.

CareFusion, a BD subsidiary, is conducting layoffs as well as moving some of its engineering and manufacturing jobs to other ...

Hurricane Helene wrecked a factory in North Carolina that produced 60% of the fluids their sustenance is mixed from.

Researchers at Michigan State University have developed a new nanotherapy infusion for the treatment of arterial plaque ...

The FDA on Thursday approved an injectable drug that eased Parkinson's disease symptoms and improved motor fluctuations in ...

The US Food and Drug Administration has approved VYALEV, a groundbreaking therapy developed by AbbVie to treat adults with ...

A patient who received a new infusion therapy treatment for Parkinson’s disease showed progress after just two days, Sherwood Forest Hospitals said.

said Thursday the Food and Drug Administration has approved its vyalev as the first and only subcutaneous 24-hour continuous infusion of levodopa-based therapy for the treatment of motor ...

Although the FDA is allowing emergency imports of IV fluids wiped out by Helene, as well as production of some of the fluids ...

Opinion: More than $55 billion in opioid settlement money has flowed into state, county, and city coffers. Much of it is at ...

While the makeup of the Franchise Times Top 400 Health & Medical category is changing, with regenerative therapy, mental ...

Positive results for Intellia Therapeutics, Inc.'s NTLA-2002 in treating HAE patients. Stock price dips, but the program ...